Using PCa xenograft tumors, CD44+ PCa cells are shown to have stem-like cancer cell properties (Patrawala et al., 2006), and CD44+α2β1+ PCa cells are further enriched in tumor-initiating cells (Patrawala et al., 2007). The gene discussed is CD44; the disease is posterior cortical atrophy.